| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Pediatric | 63 | 2024 | 1014 | 6.960 |
Why?
|
| Critical Care | 65 | 2024 | 2699 | 6.590 |
Why?
|
| Status Epilepticus | 32 | 2023 | 456 | 5.490 |
Why?
|
| Brain Injuries | 38 | 2022 | 2044 | 5.310 |
Why?
|
| Critical Illness | 44 | 2022 | 2709 | 3.470 |
Why?
|
| Intracranial Pressure | 17 | 2022 | 325 | 3.350 |
Why?
|
| Brain Death | 8 | 2023 | 356 | 3.170 |
Why?
|
| Pediatrics | 30 | 2024 | 3586 | 2.590 |
Why?
|
| Intracranial Hypertension | 17 | 2023 | 193 | 2.480 |
Why?
|
| Apnea | 6 | 2020 | 195 | 2.330 |
Why?
|
| Periodicals as Topic | 8 | 2024 | 1469 | 2.280 |
Why?
|
| Craniosynostoses | 13 | 2024 | 412 | 2.220 |
Why?
|
| Shock, Septic | 15 | 2024 | 761 | 2.150 |
Why?
|
| Child | 202 | 2024 | 79806 | 2.090 |
Why?
|
| Anticonvulsants | 24 | 2023 | 1879 | 2.060 |
Why?
|
| Midazolam | 8 | 2022 | 267 | 1.850 |
Why?
|
| Respiration, Artificial | 27 | 2021 | 2622 | 1.760 |
Why?
|
| Multiple Organ Failure | 10 | 2022 | 386 | 1.640 |
Why?
|
| Writing | 3 | 2024 | 199 | 1.620 |
Why?
|
| Diabetic Ketoacidosis | 7 | 2020 | 257 | 1.600 |
Why?
|
| Cerebrovascular Circulation | 18 | 2020 | 2733 | 1.590 |
Why?
|
| Sepsis | 18 | 2024 | 2592 | 1.550 |
Why?
|
| Hypothermia, Induced | 9 | 2019 | 758 | 1.540 |
Why?
|
| Coma | 11 | 2020 | 487 | 1.360 |
Why?
|
| Child, Preschool | 122 | 2024 | 42063 | 1.360 |
Why?
|
| Hypoglycemia | 8 | 2014 | 888 | 1.340 |
Why?
|
| Delirium | 7 | 2024 | 1663 | 1.300 |
Why?
|
| Hyperglycemia | 12 | 2014 | 1380 | 1.280 |
Why?
|
| Infant | 116 | 2024 | 36060 | 1.250 |
Why?
|
| Monitoring, Physiologic | 19 | 2021 | 1784 | 1.220 |
Why?
|
| Water-Electrolyte Imbalance | 2 | 2020 | 109 | 1.110 |
Why?
|
| Seizures | 17 | 2023 | 2917 | 1.090 |
Why?
|
| Humans | 325 | 2024 | 760621 | 1.080 |
Why?
|
| Glasgow Coma Scale | 14 | 2024 | 579 | 1.050 |
Why?
|
| Brain Diseases | 7 | 2022 | 1540 | 1.030 |
Why?
|
| Brain Edema | 6 | 2014 | 603 | 0.990 |
Why?
|
| Blood Glucose | 11 | 2014 | 6381 | 0.920 |
Why?
|
| Respiratory Insufficiency | 13 | 2022 | 1231 | 0.910 |
Why?
|
| Hypnotics and Sedatives | 4 | 2018 | 1178 | 0.890 |
Why?
|
| Hydrocortisone | 5 | 2015 | 1803 | 0.870 |
Why?
|
| Heart Arrest | 7 | 2017 | 1506 | 0.870 |
Why?
|
| Pentobarbital | 3 | 2022 | 153 | 0.860 |
Why?
|
| Infant, Newborn | 60 | 2024 | 26181 | 0.830 |
Why?
|
| Diagnostic Techniques, Neurological | 2 | 2020 | 62 | 0.810 |
Why?
|
| Cholinergic Antagonists | 3 | 2021 | 164 | 0.800 |
Why?
|
| Neurology | 6 | 2023 | 779 | 0.800 |
Why?
|
| High-Frequency Ventilation | 5 | 2008 | 88 | 0.790 |
Why?
|
| Extracorporeal Membrane Oxygenation | 7 | 2020 | 1459 | 0.790 |
Why?
|
| Hypoxia, Brain | 3 | 2014 | 138 | 0.770 |
Why?
|
| Brain | 16 | 2022 | 26951 | 0.750 |
Why?
|
| Brain Concussion | 3 | 2019 | 1394 | 0.740 |
Why?
|
| Epinephrine | 2 | 2015 | 791 | 0.740 |
Why?
|
| Central Nervous System Diseases | 5 | 2020 | 521 | 0.720 |
Why?
|
| Cholinesterases | 1 | 2020 | 32 | 0.720 |
Why?
|
| Electroencephalography | 20 | 2024 | 6189 | 0.720 |
Why?
|
| Paralysis | 1 | 2022 | 251 | 0.720 |
Why?
|
| Unconsciousness | 2 | 2020 | 251 | 0.720 |
Why?
|
| Benzodiazepines | 9 | 2023 | 1131 | 0.720 |
Why?
|
| Catastrophic Illness | 1 | 2020 | 59 | 0.710 |
Why?
|
| Cardiopulmonary Resuscitation | 4 | 2017 | 1004 | 0.700 |
Why?
|
| Adolescent | 91 | 2024 | 87810 | 0.690 |
Why?
|
| Clinical Protocols | 7 | 2022 | 1440 | 0.690 |
Why?
|
| Respiratory Syncytial Virus Infections | 5 | 2008 | 364 | 0.690 |
Why?
|
| Hospital Mortality | 14 | 2022 | 5425 | 0.680 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 4 | 2020 | 281 | 0.680 |
Why?
|
| Craniocerebral Trauma | 6 | 2006 | 491 | 0.660 |
Why?
|
| Malformations of Cortical Development | 1 | 2021 | 177 | 0.660 |
Why?
|
| Shock | 2 | 2015 | 317 | 0.640 |
Why?
|
| Anesthesia, General | 3 | 2017 | 1166 | 0.640 |
Why?
|
| Nervous System Diseases | 4 | 2022 | 1647 | 0.640 |
Why?
|
| Bioethical Issues | 1 | 2020 | 121 | 0.640 |
Why?
|
| Blood Flow Velocity | 4 | 2019 | 1377 | 0.620 |
Why?
|
| Fluid Therapy | 9 | 2020 | 579 | 0.610 |
Why?
|
| Carbon Dioxide | 7 | 2020 | 1146 | 0.610 |
Why?
|
| Polyneuropathies | 1 | 2019 | 137 | 0.610 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2020 | 227 | 0.600 |
Why?
|
| Barbiturates | 4 | 2019 | 113 | 0.600 |
Why?
|
| Hyperoxia | 1 | 2020 | 250 | 0.600 |
Why?
|
| Decompressive Craniectomy | 4 | 2020 | 76 | 0.600 |
Why?
|
| Patient Selection | 6 | 2019 | 4283 | 0.590 |
Why?
|
| Research Report | 1 | 2021 | 370 | 0.590 |
Why?
|
| S100 Proteins | 2 | 2009 | 218 | 0.580 |
Why?
|
| Somatotrophs | 1 | 2017 | 2 | 0.580 |
Why?
|
| Bronchiolitis, Viral | 2 | 2008 | 82 | 0.570 |
Why?
|
| Oxygen | 10 | 2020 | 4193 | 0.560 |
Why?
|
| Hypopituitarism | 3 | 2007 | 248 | 0.560 |
Why?
|
| Trauma Severity Indices | 3 | 2014 | 478 | 0.560 |
Why?
|
| Erythrocyte Transfusion | 2 | 2018 | 566 | 0.550 |
Why?
|
| Cerebral Veins | 1 | 2018 | 157 | 0.550 |
Why?
|
| Consciousness Disorders | 2 | 2020 | 440 | 0.550 |
Why?
|
| Drowning | 1 | 2016 | 26 | 0.550 |
Why?
|
| Off-Label Use | 1 | 2018 | 184 | 0.540 |
Why?
|
| Glucose Clamp Technique | 1 | 2017 | 263 | 0.540 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2017 | 172 | 0.530 |
Why?
|
| Headache Disorders | 1 | 2018 | 148 | 0.530 |
Why?
|
| Practice Guidelines as Topic | 17 | 2020 | 7475 | 0.530 |
Why?
|
| Intensive Care, Neonatal | 6 | 2018 | 197 | 0.520 |
Why?
|
| Diazepam | 3 | 2023 | 215 | 0.520 |
Why?
|
| Male | 124 | 2024 | 359744 | 0.510 |
Why?
|
| Neuroprotective Agents | 3 | 2016 | 961 | 0.500 |
Why?
|
| Neurosecretory Systems | 2 | 2008 | 221 | 0.500 |
Why?
|
| Nerve Growth Factors | 2 | 2009 | 562 | 0.490 |
Why?
|
| Ischemic Attack, Transient | 3 | 2015 | 901 | 0.490 |
Why?
|
| Head | 3 | 2017 | 922 | 0.480 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2015 | 178 | 0.480 |
Why?
|
| Bronchiolitis | 3 | 2013 | 481 | 0.470 |
Why?
|
| Female | 117 | 2024 | 391270 | 0.470 |
Why?
|
| Homeostasis | 5 | 2019 | 3306 | 0.460 |
Why?
|
| Disclosure | 1 | 2020 | 738 | 0.460 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 696 | 0.460 |
Why?
|
| Cerebral Cortex | 6 | 2021 | 5761 | 0.460 |
Why?
|
| Sodium Chloride | 3 | 2013 | 591 | 0.460 |
Why?
|
| Movement Disorders | 2 | 2017 | 459 | 0.460 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2015 | 345 | 0.450 |
Why?
|
| Central Nervous System Infections | 1 | 2014 | 61 | 0.450 |
Why?
|
| Informed Consent | 2 | 2017 | 1005 | 0.450 |
Why?
|
| England | 11 | 2014 | 526 | 0.450 |
Why?
|
| Neurosurgery | 2 | 2019 | 670 | 0.440 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2014 | 114 | 0.440 |
Why?
|
| Mannitol | 1 | 2014 | 180 | 0.440 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 296 | 0.440 |
Why?
|
| Intubation, Intratracheal | 5 | 2013 | 1328 | 0.430 |
Why?
|
| Hypoglycemic Agents | 6 | 2017 | 3150 | 0.430 |
Why?
|
| Patient Positioning | 1 | 2016 | 327 | 0.430 |
Why?
|
| Hemodynamics | 8 | 2020 | 4174 | 0.430 |
Why?
|
| Tissue and Organ Procurement | 2 | 2020 | 944 | 0.430 |
Why?
|
| Child Development | 2 | 2016 | 2285 | 0.430 |
Why?
|
| Anastomosis, Surgical | 2 | 2015 | 983 | 0.430 |
Why?
|
| Insulin | 9 | 2017 | 6597 | 0.420 |
Why?
|
| Brain Damage, Chronic | 3 | 2005 | 267 | 0.420 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2013 | 58 | 0.420 |
Why?
|
| Intensive Care Units | 11 | 2022 | 3736 | 0.420 |
Why?
|
| Hydrodynamics | 1 | 2013 | 167 | 0.410 |
Why?
|
| Bayes Theorem | 3 | 2019 | 2326 | 0.410 |
Why?
|
| Moyamoya Disease | 1 | 2015 | 255 | 0.410 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2017 | 622 | 0.410 |
Why?
|
| Drug Utilization | 1 | 2018 | 1195 | 0.410 |
Why?
|
| Cerebral Infarction | 1 | 2017 | 982 | 0.400 |
Why?
|
| Glycemic Index | 3 | 2011 | 396 | 0.400 |
Why?
|
| Autonomic Nervous System | 1 | 2017 | 697 | 0.400 |
Why?
|
| Coronary Care Units | 1 | 2013 | 235 | 0.400 |
Why?
|
| Patient Discharge | 3 | 2019 | 3476 | 0.400 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2009 | 127 | 0.390 |
Why?
|
| Brain Ischemia | 7 | 2015 | 3127 | 0.390 |
Why?
|
| Health Status Indicators | 1 | 2017 | 968 | 0.390 |
Why?
|
| Infusions, Intravenous | 7 | 2020 | 2234 | 0.380 |
Why?
|
| Anesthetics, Intravenous | 1 | 2014 | 397 | 0.380 |
Why?
|
| Hypovolemia | 3 | 2006 | 48 | 0.370 |
Why?
|
| Stroke | 5 | 2020 | 9962 | 0.370 |
Why?
|
| Neuromuscular Diseases | 1 | 2013 | 256 | 0.370 |
Why?
|
| Attitude | 1 | 2016 | 777 | 0.370 |
Why?
|
| Models, Biological | 4 | 2018 | 9467 | 0.370 |
Why?
|
| Vasoconstrictor Agents | 5 | 2020 | 651 | 0.370 |
Why?
|
| Neuroimmunomodulation | 3 | 2018 | 177 | 0.360 |
Why?
|
| Influenza A Virus, H1N2 Subtype | 1 | 2010 | 4 | 0.360 |
Why?
|
| Blood Pressure | 9 | 2019 | 8525 | 0.360 |
Why?
|
| Body Temperature | 1 | 2013 | 777 | 0.360 |
Why?
|
| Croup | 2 | 2003 | 23 | 0.350 |
Why?
|
| Hypotension | 3 | 2014 | 883 | 0.350 |
Why?
|
| Severity of Illness Index | 15 | 2024 | 15840 | 0.350 |
Why?
|
| Organ Transplantation | 1 | 2020 | 1150 | 0.350 |
Why?
|
| Nitric Oxide | 9 | 2002 | 2141 | 0.340 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2015 | 1190 | 0.340 |
Why?
|
| Perfusion | 1 | 2014 | 1376 | 0.340 |
Why?
|
| Trauma, Nervous System | 1 | 2009 | 35 | 0.330 |
Why?
|
| Mountaineering | 1 | 2009 | 45 | 0.330 |
Why?
|
| Enteral Nutrition | 3 | 2021 | 785 | 0.320 |
Why?
|
| Epilepsy | 3 | 2021 | 3267 | 0.310 |
Why?
|
| Prosencephalon | 1 | 2010 | 305 | 0.310 |
Why?
|
| Resuscitation | 4 | 2020 | 661 | 0.310 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2022 | 10344 | 0.310 |
Why?
|
| Infant, Premature | 3 | 2016 | 2092 | 0.310 |
Why?
|
| Hyperventilation | 3 | 2005 | 79 | 0.310 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 1902 | 0.310 |
Why?
|
| Oxyhemoglobins | 1 | 2009 | 212 | 0.300 |
Why?
|
| Prospective Studies | 34 | 2021 | 54303 | 0.300 |
Why?
|
| Cognition Disorders | 3 | 2012 | 3976 | 0.300 |
Why?
|
| Altitude | 1 | 2009 | 159 | 0.300 |
Why?
|
| Corpus Callosum | 2 | 2022 | 749 | 0.290 |
Why?
|
| Intelligence | 1 | 2012 | 921 | 0.290 |
Why?
|
| Posture | 1 | 2012 | 953 | 0.290 |
Why?
|
| Monitoring, Intraoperative | 1 | 2014 | 942 | 0.290 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2011 | 485 | 0.290 |
Why?
|
| Meningitis, Meningococcal | 1 | 2007 | 44 | 0.290 |
Why?
|
| Hippocampus | 7 | 2006 | 3738 | 0.280 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 3 | 2016 | 347 | 0.280 |
Why?
|
| Positive-Pressure Respiration | 4 | 1999 | 636 | 0.280 |
Why?
|
| Biomedical Research | 3 | 2020 | 3426 | 0.280 |
Why?
|
| Patient Transfer | 4 | 2010 | 779 | 0.280 |
Why?
|
| Models, Statistical | 3 | 2017 | 5075 | 0.270 |
Why?
|
| Hospitals | 2 | 2020 | 3928 | 0.270 |
Why?
|
| Retrospective Studies | 36 | 2024 | 80372 | 0.260 |
Why?
|
| Perioperative Care | 1 | 2014 | 1037 | 0.260 |
Why?
|
| Pneumonia, Ventilator-Associated | 2 | 2008 | 278 | 0.260 |
Why?
|
| Pulmonary Gas Exchange | 5 | 2014 | 378 | 0.260 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1398 | 0.260 |
Why?
|
| Retinal Hemorrhage | 2 | 2004 | 95 | 0.260 |
Why?
|
| Encephalocele | 2 | 2020 | 135 | 0.260 |
Why?
|
| Hypothalamic Diseases | 1 | 2007 | 134 | 0.260 |
Why?
|
| Migraine Disorders | 1 | 2018 | 1693 | 0.260 |
Why?
|
| Diffuse Axonal Injury | 1 | 2006 | 49 | 0.260 |
Why?
|
| Energy Metabolism | 5 | 2014 | 2869 | 0.260 |
Why?
|
| Acrocephalosyndactylia | 2 | 2021 | 91 | 0.260 |
Why?
|
| Hematoma, Subdural | 2 | 2004 | 126 | 0.250 |
Why?
|
| Lymphopenia | 2 | 2004 | 280 | 0.250 |
Why?
|
| Ambulances | 1 | 2005 | 92 | 0.250 |
Why?
|
| Adrenal Insufficiency | 1 | 2007 | 192 | 0.250 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2021 | 577 | 0.250 |
Why?
|
| Child Mortality | 2 | 2014 | 205 | 0.250 |
Why?
|
| Ferritins | 1 | 2007 | 597 | 0.240 |
Why?
|
| Polysomnography | 5 | 2024 | 1825 | 0.240 |
Why?
|
| Death | 3 | 2020 | 678 | 0.240 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 3865 | 0.240 |
Why?
|
| Length of Stay | 9 | 2020 | 6479 | 0.240 |
Why?
|
| Encephalitis | 2 | 2018 | 437 | 0.240 |
Why?
|
| Phenotype | 3 | 2022 | 16546 | 0.230 |
Why?
|
| Parainfluenza Virus 2, Human | 1 | 2003 | 8 | 0.230 |
Why?
|
| Persistent Fetal Circulation Syndrome | 3 | 1999 | 80 | 0.230 |
Why?
|
| Anesthesiology | 1 | 2014 | 1116 | 0.220 |
Why?
|
| Pulmonary Medicine | 1 | 2006 | 221 | 0.220 |
Why?
|
| Battered Child Syndrome | 1 | 2003 | 11 | 0.220 |
Why?
|
| Growth Hormone | 1 | 2005 | 568 | 0.220 |
Why?
|
| Guidelines as Topic | 2 | 2020 | 1392 | 0.220 |
Why?
|
| Wales | 4 | 2010 | 86 | 0.220 |
Why?
|
| Hemostasis | 1 | 2006 | 468 | 0.210 |
Why?
|
| Hemoglobins | 1 | 2009 | 1521 | 0.210 |
Why?
|
| Isotonic Solutions | 4 | 2006 | 116 | 0.210 |
Why?
|
| Pneumonia, Pneumocystis | 2 | 1995 | 245 | 0.210 |
Why?
|
| Acute Disease | 11 | 2017 | 7269 | 0.210 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2004 | 125 | 0.210 |
Why?
|
| Treatment Outcome | 27 | 2021 | 65017 | 0.210 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2024 | 1860 | 0.210 |
Why?
|
| Evidence-Based Medicine | 7 | 2022 | 3696 | 0.210 |
Why?
|
| Prolactin | 1 | 2004 | 621 | 0.210 |
Why?
|
| Athletic Injuries | 1 | 2012 | 1209 | 0.210 |
Why?
|
| Skull | 2 | 2005 | 815 | 0.210 |
Why?
|
| Hematology | 1 | 2006 | 241 | 0.200 |
Why?
|
| Life Support Care | 2 | 2011 | 222 | 0.200 |
Why?
|
| Hospitalization | 12 | 2018 | 10790 | 0.200 |
Why?
|
| Cerebrovascular Disorders | 1 | 2009 | 1501 | 0.200 |
Why?
|
| Cohort Studies | 12 | 2021 | 41335 | 0.200 |
Why?
|
| History, 20th Century | 2 | 2024 | 2773 | 0.200 |
Why?
|
| Time Factors | 22 | 2021 | 40165 | 0.200 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2002 | 103 | 0.190 |
Why?
|
| Masks | 1 | 2003 | 209 | 0.190 |
Why?
|
| Peer Review | 1 | 2023 | 218 | 0.190 |
Why?
|
| Papilledema | 2 | 2016 | 130 | 0.190 |
Why?
|
| Anesthetics, Inhalation | 2 | 2017 | 574 | 0.180 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2001 | 106 | 0.180 |
Why?
|
| Pilot Projects | 4 | 2018 | 8555 | 0.180 |
Why?
|
| Emergency Treatment | 2 | 2018 | 498 | 0.180 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2005 | 621 | 0.180 |
Why?
|
| Seizures, Febrile | 1 | 2021 | 108 | 0.170 |
Why?
|
| Consensus | 5 | 2020 | 3113 | 0.170 |
Why?
|
| Recovery of Function | 1 | 2010 | 2985 | 0.170 |
Why?
|
| Research Design | 7 | 2022 | 6180 | 0.170 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2006 | 952 | 0.170 |
Why?
|
| Respiration Disorders | 2 | 2004 | 368 | 0.170 |
Why?
|
| Withholding Treatment | 2 | 2011 | 613 | 0.170 |
Why?
|
| Statistics, Nonparametric | 5 | 2018 | 2852 | 0.170 |
Why?
|
| Albumins | 1 | 2002 | 575 | 0.170 |
Why?
|
| Hospitals, Pediatric | 6 | 2020 | 1854 | 0.160 |
Why?
|
| Dantrolene | 1 | 1998 | 26 | 0.160 |
Why?
|
| Sensitivity and Specificity | 6 | 2023 | 14660 | 0.160 |
Why?
|
| Serum Albumin | 1 | 2002 | 674 | 0.160 |
Why?
|
| Emergency Service, Hospital | 5 | 2017 | 7818 | 0.160 |
Why?
|
| Animals, Newborn | 3 | 2016 | 2672 | 0.160 |
Why?
|
| Oxidative Stress | 2 | 2010 | 3106 | 0.160 |
Why?
|
| United States | 11 | 2020 | 72461 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2010 | 1528 | 0.160 |
Why?
|
| Achondroplasia | 1 | 1998 | 28 | 0.160 |
Why?
|
| Bioethics | 1 | 2020 | 117 | 0.160 |
Why?
|
| Clinical Trials Data Monitoring Committees | 1 | 2018 | 26 | 0.160 |
Why?
|
| Photoperiod | 1 | 2019 | 139 | 0.160 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2018 | 38 | 0.150 |
Why?
|
| Erythrocyte Count | 1 | 2018 | 157 | 0.150 |
Why?
|
| Catheter-Related Infections | 1 | 2011 | 273 | 0.150 |
Why?
|
| Hepatic Encephalopathy | 1 | 2019 | 144 | 0.150 |
Why?
|
| Decision Making | 4 | 2018 | 3925 | 0.150 |
Why?
|
| Hypertonic Solutions | 3 | 2004 | 82 | 0.150 |
Why?
|
| Plasma Substitutes | 3 | 2004 | 57 | 0.150 |
Why?
|
| Acetylcholine | 1 | 2020 | 629 | 0.150 |
Why?
|
| Cytokines | 3 | 2017 | 7343 | 0.150 |
Why?
|
| History, 21st Century | 1 | 2024 | 1575 | 0.150 |
Why?
|
| Respiratory Tract Infections | 2 | 2003 | 1007 | 0.150 |
Why?
|
| Sleep Apnea Syndromes | 3 | 2015 | 974 | 0.150 |
Why?
|
| Feeding Methods | 1 | 2017 | 35 | 0.150 |
Why?
|
| Neurotoxins | 3 | 1995 | 240 | 0.150 |
Why?
|
| Rehydration Solutions | 3 | 2004 | 43 | 0.150 |
Why?
|
| Centralized Hospital Services | 1 | 1997 | 19 | 0.150 |
Why?
|
| Reperfusion | 1 | 1998 | 271 | 0.150 |
Why?
|
| Bed Occupancy | 1 | 1997 | 38 | 0.150 |
Why?
|
| Liver Failure, Acute | 1 | 2019 | 181 | 0.150 |
Why?
|
| Brain Stem | 2 | 2020 | 857 | 0.150 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 8986 | 0.150 |
Why?
|
| Emergencies | 3 | 2016 | 1211 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2001 | 893 | 0.140 |
Why?
|
| Moral Development | 1 | 2016 | 13 | 0.140 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2018 | 303 | 0.140 |
Why?
|
| ROC Curve | 4 | 2014 | 3568 | 0.140 |
Why?
|
| Parents | 2 | 2014 | 3549 | 0.140 |
Why?
|
| Postoperative Complications | 7 | 2014 | 15697 | 0.140 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2018 | 231 | 0.140 |
Why?
|
| Inflammation | 1 | 2017 | 10756 | 0.140 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1998 | 428 | 0.140 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2005 | 1869 | 0.140 |
Why?
|
| Staphylococcal Infections | 1 | 2005 | 1407 | 0.140 |
Why?
|
| Parenteral Nutrition | 2 | 2018 | 656 | 0.140 |
Why?
|
| Meningitis | 1 | 1998 | 218 | 0.140 |
Why?
|
| Leptin | 1 | 2004 | 1591 | 0.140 |
Why?
|
| Prognosis | 14 | 2022 | 29658 | 0.140 |
Why?
|
| Muscle Weakness | 1 | 2019 | 413 | 0.130 |
Why?
|
| Young Adult | 12 | 2021 | 58741 | 0.130 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 125 | 0.130 |
Why?
|
| Snoring | 1 | 2017 | 206 | 0.130 |
Why?
|
| Dizocilpine Maleate | 2 | 1994 | 172 | 0.130 |
Why?
|
| Intracranial Hemorrhages | 2 | 2017 | 844 | 0.130 |
Why?
|
| Immune System Diseases | 1 | 2018 | 258 | 0.130 |
Why?
|
| Myasthenia Gravis | 1 | 1998 | 213 | 0.130 |
Why?
|
| Speech Disorders | 1 | 2016 | 180 | 0.130 |
Why?
|
| Supine Position | 1 | 2016 | 205 | 0.130 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 1995 | 41 | 0.130 |
Why?
|
| Intention to Treat Analysis | 1 | 2016 | 422 | 0.130 |
Why?
|
| Medical Futility | 1 | 1996 | 133 | 0.120 |
Why?
|
| Lung | 5 | 2016 | 9994 | 0.120 |
Why?
|
| Language Development Disorders | 1 | 2016 | 192 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2020 | 10827 | 0.120 |
Why?
|
| Lidocaine | 1 | 2018 | 538 | 0.120 |
Why?
|
| Altitude Sickness | 1 | 2016 | 91 | 0.120 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 1995 | 30 | 0.120 |
Why?
|
| Tetrodotoxin | 2 | 1994 | 246 | 0.120 |
Why?
|
| Acute Kidney Injury | 3 | 2006 | 1941 | 0.120 |
Why?
|
| Pertussis Vaccine | 1 | 1994 | 39 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2012 | 20509 | 0.120 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2017 | 415 | 0.120 |
Why?
|
| Neurons | 4 | 2012 | 9426 | 0.120 |
Why?
|
| Adult | 21 | 2023 | 219994 | 0.120 |
Why?
|
| Internationality | 1 | 2020 | 1004 | 0.120 |
Why?
|
| Carbon Monoxide | 1 | 1998 | 540 | 0.120 |
Why?
|
| Palliative Care | 2 | 2010 | 3607 | 0.120 |
Why?
|
| Comprehension | 1 | 2020 | 618 | 0.120 |
Why?
|
| Iatrogenic Disease | 1 | 2018 | 538 | 0.120 |
Why?
|
| Review Literature as Topic | 1 | 2016 | 349 | 0.120 |
Why?
|
| Pulmonary Surfactants | 1 | 1995 | 161 | 0.120 |
Why?
|
| Brazil | 2 | 2011 | 1218 | 0.120 |
Why?
|
| Cell Enlargement | 1 | 2014 | 60 | 0.120 |
Why?
|
| Abdomen | 1 | 2020 | 1130 | 0.120 |
Why?
|
| Clinical Trials as Topic | 3 | 2018 | 8056 | 0.120 |
Why?
|
| Methylprednisolone | 1 | 1996 | 384 | 0.120 |
Why?
|
| Bereavement | 2 | 2018 | 307 | 0.120 |
Why?
|
| Follow-Up Studies | 10 | 2023 | 39261 | 0.110 |
Why?
|
| Logistic Models | 4 | 2008 | 13314 | 0.110 |
Why?
|
| Neuroblastoma | 1 | 2002 | 1252 | 0.110 |
Why?
|
| Risk Factors | 11 | 2020 | 74359 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2005 | 2502 | 0.110 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 1997 | 316 | 0.110 |
Why?
|
| Hypercapnia | 1 | 1995 | 261 | 0.110 |
Why?
|
| Emergency Medical Services | 2 | 2020 | 1925 | 0.110 |
Why?
|
| Immunization, Secondary | 2 | 1999 | 368 | 0.110 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 894 | 0.110 |
Why?
|
| Receptors, Amino Acid | 1 | 1992 | 30 | 0.110 |
Why?
|
| Severe Acute Respiratory Syndrome | 2 | 2004 | 137 | 0.110 |
Why?
|
| Bronchi | 1 | 1997 | 848 | 0.110 |
Why?
|
| Syndrome | 5 | 2020 | 3280 | 0.110 |
Why?
|
| Feedback | 1 | 2017 | 791 | 0.110 |
Why?
|
| Injections, Intramuscular | 1 | 2014 | 553 | 0.110 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2018 | 786 | 0.110 |
Why?
|
| India | 1 | 2019 | 2336 | 0.100 |
Why?
|
| Education, Medical, Graduate | 2 | 2006 | 2363 | 0.100 |
Why?
|
| Neurologic Examination | 3 | 2023 | 916 | 0.100 |
Why?
|
| Hernia, Umbilical | 1 | 1993 | 102 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 2 | 2023 | 2884 | 0.100 |
Why?
|
| Health Care Costs | 3 | 2014 | 3258 | 0.100 |
Why?
|
| Multivariate Analysis | 3 | 2020 | 12159 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 20080 | 0.100 |
Why?
|
| Laryngeal Neoplasms | 1 | 1996 | 514 | 0.100 |
Why?
|
| Medical Errors | 1 | 2000 | 1255 | 0.100 |
Why?
|
| Trachea | 2 | 1997 | 1082 | 0.100 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 1385 | 0.100 |
Why?
|
| Human Growth Hormone | 1 | 2017 | 638 | 0.100 |
Why?
|
| Conscious Sedation | 1 | 2016 | 529 | 0.100 |
Why?
|
| Analgesia | 1 | 2016 | 459 | 0.100 |
Why?
|
| Guideline Adherence | 2 | 2020 | 2283 | 0.100 |
Why?
|
| Neonatology | 1 | 2013 | 140 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2021 | 36290 | 0.100 |
Why?
|
| Isoflurane | 1 | 2014 | 384 | 0.100 |
Why?
|
| Administration, Inhalation | 7 | 2002 | 1156 | 0.100 |
Why?
|
| Erythropoietin | 1 | 2016 | 720 | 0.090 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 1991 | 38 | 0.090 |
Why?
|
| Analysis of Variance | 6 | 2017 | 6238 | 0.090 |
Why?
|
| Nausea | 1 | 2014 | 678 | 0.090 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 2061 | 0.090 |
Why?
|
| Ventilator Weaning | 3 | 2010 | 161 | 0.090 |
Why?
|
| Capillary Permeability | 1 | 2014 | 768 | 0.090 |
Why?
|
| Hemangioma | 1 | 1996 | 728 | 0.090 |
Why?
|
| Data Collection | 1 | 2020 | 3315 | 0.090 |
Why?
|
| Quality of Life | 4 | 2022 | 13308 | 0.090 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2010 | 75 | 0.080 |
Why?
|
| Thiopental | 1 | 1989 | 55 | 0.080 |
Why?
|
| Diagnosis, Differential | 4 | 2017 | 12965 | 0.080 |
Why?
|
| Health Care Surveys | 2 | 2011 | 2435 | 0.080 |
Why?
|
| Rats | 8 | 2016 | 23711 | 0.080 |
Why?
|
| Pain | 1 | 2004 | 5066 | 0.080 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2014 | 833 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 1928 | 0.080 |
Why?
|
| Anemia | 1 | 2018 | 1511 | 0.080 |
Why?
|
| Ketamine | 1 | 2014 | 516 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2007 | 6360 | 0.080 |
Why?
|
| Argentina | 1 | 2009 | 245 | 0.080 |
Why?
|
| Catheters, Indwelling | 1 | 1991 | 428 | 0.080 |
Why?
|
| Drug Design | 1 | 2013 | 1061 | 0.080 |
Why?
|
| Pituitary Gland | 2 | 2008 | 637 | 0.080 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2009 | 278 | 0.080 |
Why?
|
| Analgesics, Opioid | 1 | 2004 | 3763 | 0.080 |
Why?
|
| Culture Techniques | 3 | 2001 | 530 | 0.080 |
Why?
|
| Craniofacial Dysostosis | 1 | 2008 | 74 | 0.070 |
Why?
|
| Analgesics | 1 | 2014 | 1065 | 0.070 |
Why?
|
| Spasms, Infantile | 1 | 1991 | 296 | 0.070 |
Why?
|
| Blood-Brain Barrier | 1 | 2014 | 1019 | 0.070 |
Why?
|
| Complementary Therapies | 1 | 2011 | 486 | 0.070 |
Why?
|
| Aging | 2 | 2004 | 8651 | 0.070 |
Why?
|
| Bronchodilator Agents | 2 | 2002 | 506 | 0.070 |
Why?
|
| Phosphocreatine | 2 | 2000 | 261 | 0.070 |
Why?
|
| Sleep Stages | 2 | 2024 | 691 | 0.070 |
Why?
|
| Respiratory System Agents | 2 | 1997 | 30 | 0.070 |
Why?
|
| Radiography | 2 | 2014 | 6965 | 0.070 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 367 | 0.070 |
Why?
|
| Europe | 4 | 2013 | 3441 | 0.070 |
Why?
|
| Risk Adjustment | 1 | 2010 | 601 | 0.070 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2011 | 599 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2024 | 4775 | 0.070 |
Why?
|
| Cerebral Hemorrhage, Traumatic | 1 | 2006 | 20 | 0.070 |
Why?
|
| Shaken Baby Syndrome | 2 | 2004 | 24 | 0.070 |
Why?
|
| Thrombolytic Therapy | 1 | 2015 | 2108 | 0.070 |
Why?
|
| Whooping Cough | 2 | 1999 | 85 | 0.070 |
Why?
|
| Drug Administration Schedule | 2 | 2018 | 4899 | 0.070 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2022 | 2385 | 0.070 |
Why?
|
| Astrocytes | 1 | 2014 | 1338 | 0.070 |
Why?
|
| Bicarbonates | 2 | 2005 | 292 | 0.070 |
Why?
|
| Poverty Areas | 3 | 2018 | 264 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 1996 | 2145 | 0.070 |
Why?
|
| Occupational Diseases | 1 | 2014 | 1486 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6498 | 0.070 |
Why?
|
| Patient Admission | 2 | 2015 | 1386 | 0.070 |
Why?
|
| Diagnosis-Related Groups | 2 | 1998 | 450 | 0.070 |
Why?
|
| Hyponatremia | 1 | 2009 | 279 | 0.070 |
Why?
|
| State Medicine | 1 | 2007 | 213 | 0.070 |
Why?
|
| Microcirculation | 1 | 2011 | 1278 | 0.070 |
Why?
|
| Ireland | 3 | 2015 | 172 | 0.070 |
Why?
|
| Heart Rate | 1 | 2017 | 4179 | 0.070 |
Why?
|
| Transportation of Patients | 2 | 2018 | 176 | 0.070 |
Why?
|
| Behavior Therapy | 1 | 2011 | 868 | 0.070 |
Why?
|
| Cerebral Arteries | 1 | 1988 | 493 | 0.070 |
Why?
|
| Child Behavior | 1 | 2011 | 847 | 0.060 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1995 | 1547 | 0.060 |
Why?
|
| Electrocardiography | 2 | 2017 | 6414 | 0.060 |
Why?
|
| Burnout, Professional | 1 | 2014 | 702 | 0.060 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 2167 | 0.060 |
Why?
|
| Hospitals, University | 1 | 2007 | 568 | 0.060 |
Why?
|
| Oximetry | 1 | 2009 | 461 | 0.060 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 1913 | 0.060 |
Why?
|
| Societies, Medical | 3 | 2023 | 3905 | 0.060 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2009 | 352 | 0.060 |
Why?
|
| Reference Standards | 1 | 2009 | 1004 | 0.060 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2007 | 618 | 0.060 |
Why?
|
| Patient Care Team | 4 | 2011 | 2511 | 0.060 |
Why?
|
| Brain Hemorrhage, Traumatic | 1 | 2004 | 18 | 0.060 |
Why?
|
| Point-of-Care Systems | 1 | 2014 | 1204 | 0.060 |
Why?
|
| Adrenal Gland Diseases | 1 | 2005 | 141 | 0.060 |
Why?
|
| Acid-Base Equilibrium | 1 | 2005 | 180 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 3604 | 0.060 |
Why?
|
| Social Support | 1 | 2014 | 2145 | 0.060 |
Why?
|
| Risk | 2 | 2007 | 9631 | 0.060 |
Why?
|
| Sleep | 2 | 2017 | 4751 | 0.060 |
Why?
|
| Medical History Taking | 2 | 2006 | 773 | 0.060 |
Why?
|
| N-Methylaspartate | 3 | 1995 | 231 | 0.060 |
Why?
|
| Diffusion | 1 | 2005 | 813 | 0.050 |
Why?
|
| Hormones | 1 | 2007 | 867 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
| Kenya | 2 | 2018 | 749 | 0.050 |
Why?
|
| Osmolar Concentration | 2 | 2002 | 660 | 0.050 |
Why?
|
| Heart | 1 | 2016 | 4393 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2007 | 1180 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 1993 | 1570 | 0.050 |
Why?
|
| Colloids | 1 | 2002 | 122 | 0.050 |
Why?
|
| Cross Infection | 2 | 2004 | 1434 | 0.050 |
Why?
|
| Airway Obstruction | 2 | 1998 | 662 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 1296 | 0.050 |
Why?
|
| Hormone Replacement Therapy | 1 | 2007 | 755 | 0.050 |
Why?
|
| Spinal Puncture | 1 | 2004 | 281 | 0.050 |
Why?
|
| Hemorrhage | 2 | 2005 | 3600 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2000 | 1993 | 0.050 |
Why?
|
| Radiation Dosage | 2 | 2012 | 1958 | 0.050 |
Why?
|
| Long-Term Care | 1 | 2006 | 632 | 0.050 |
Why?
|
| Professional-Family Relations | 1 | 2005 | 495 | 0.050 |
Why?
|
| Plastics | 1 | 2022 | 115 | 0.050 |
Why?
|
| Medical Audit | 3 | 2009 | 452 | 0.050 |
Why?
|
| Cheyne-Stokes Respiration | 1 | 2021 | 38 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2006 | 748 | 0.050 |
Why?
|
| Diuretics, Osmotic | 1 | 2001 | 33 | 0.050 |
Why?
|
| Equipment Failure | 1 | 2003 | 577 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2021 | 8035 | 0.050 |
Why?
|
| Survival Rate | 5 | 2005 | 12808 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 5508 | 0.050 |
Why?
|
| Dura Mater | 1 | 2003 | 290 | 0.050 |
Why?
|
| Glutamates | 2 | 1992 | 391 | 0.050 |
Why?
|
| Atrophy | 1 | 2006 | 1627 | 0.050 |
Why?
|
| Energy Intake | 2 | 2021 | 2129 | 0.040 |
Why?
|
| Research | 2 | 2006 | 1974 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2011 | 5201 | 0.040 |
Why?
|
| Iron | 1 | 2009 | 1786 | 0.040 |
Why?
|
| France | 1 | 2011 | 511 | 0.040 |
Why?
|
| Peer Review, Research | 1 | 2023 | 340 | 0.040 |
Why?
|
| Syringomyelia | 1 | 2020 | 67 | 0.040 |
Why?
|
| Phenytoin | 1 | 2020 | 188 | 0.040 |
Why?
|
| Cadaver | 2 | 2022 | 1345 | 0.040 |
Why?
|
| Phenobarbital | 1 | 2020 | 189 | 0.040 |
Why?
|
| Cognition | 1 | 2017 | 6957 | 0.040 |
Why?
|
| Glutamic Acid | 3 | 1995 | 1167 | 0.040 |
Why?
|
| Catheterization, Central Venous | 1 | 2004 | 526 | 0.040 |
Why?
|
| Respiratory Sounds | 1 | 2003 | 697 | 0.040 |
Why?
|
| Intracellular Membranes | 1 | 2000 | 389 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2023 | 22053 | 0.040 |
Why?
|
| Epilepsy, Generalized | 1 | 2021 | 178 | 0.040 |
Why?
|
| Pyridostigmine Bromide | 1 | 1998 | 31 | 0.040 |
Why?
|
| Hospice Care | 2 | 2010 | 692 | 0.040 |
Why?
|
| Algorithms | 5 | 2020 | 13981 | 0.040 |
Why?
|
| Pulmonary Heart Disease | 1 | 1998 | 34 | 0.040 |
Why?
|
| Anisotropy | 1 | 2022 | 1278 | 0.040 |
Why?
|
| Trauma Centers | 1 | 2004 | 933 | 0.040 |
Why?
|
| Adenoids | 1 | 1998 | 35 | 0.040 |
Why?
|
| Acidosis, Respiratory | 1 | 1998 | 38 | 0.040 |
Why?
|
| Viscera | 1 | 1999 | 138 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1998 | 237 | 0.040 |
Why?
|
| Optic Nerve | 1 | 2022 | 567 | 0.040 |
Why?
|
| Ion Transport | 1 | 1999 | 318 | 0.040 |
Why?
|
| Prevalence | 4 | 2020 | 15687 | 0.040 |
Why?
|
| Edema | 1 | 2002 | 769 | 0.040 |
Why?
|
| Convalescence | 1 | 1998 | 106 | 0.040 |
Why?
|
| Peer Group | 1 | 2023 | 674 | 0.040 |
Why?
|
| Palatine Tonsil | 1 | 1998 | 193 | 0.040 |
Why?
|
| Mentors | 1 | 2023 | 661 | 0.040 |
Why?
|
| Apoptosis | 2 | 2004 | 9501 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2000 | 3765 | 0.040 |
Why?
|
| Victoria | 1 | 1997 | 64 | 0.040 |
Why?
|
| Physical Examination | 1 | 2004 | 1244 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2022 | 2782 | 0.040 |
Why?
|
| Scotland | 1 | 1997 | 143 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 3340 | 0.040 |
Why?
|
| Clinical Competence | 2 | 2005 | 4783 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 1462 | 0.040 |
Why?
|
| Sex Distribution | 2 | 2015 | 2295 | 0.040 |
Why?
|
| Ghana | 1 | 2018 | 312 | 0.040 |
Why?
|
| Respiration | 2 | 2021 | 1654 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2005 | 4357 | 0.040 |
Why?
|
| Age Factors | 4 | 2020 | 18416 | 0.040 |
Why?
|
| Hyperemia | 1 | 1998 | 221 | 0.030 |
Why?
|
| Meningococcal Infections | 1 | 1997 | 78 | 0.030 |
Why?
|
| ABO Blood-Group System | 1 | 1999 | 369 | 0.030 |
Why?
|
| Immunization | 1 | 2001 | 1227 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 7021 | 0.030 |
Why?
|
| Hypertrophy | 1 | 1998 | 555 | 0.030 |
Why?
|
| Age Distribution | 2 | 2015 | 2893 | 0.030 |
Why?
|
| Animals | 12 | 2018 | 167963 | 0.030 |
Why?
|
| London | 1 | 1996 | 234 | 0.030 |
Why?
|
| Ethiopia | 1 | 2018 | 462 | 0.030 |
Why?
|
| Physicians | 1 | 2014 | 4591 | 0.030 |
Why?
|
| Globus Pallidus | 1 | 1997 | 249 | 0.030 |
Why?
|
| Incidence | 3 | 2015 | 21392 | 0.030 |
Why?
|
| Sex Factors | 2 | 2020 | 10547 | 0.030 |
Why?
|
| Immunization Programs | 1 | 1999 | 268 | 0.030 |
Why?
|
| Epoetin Alfa | 1 | 2016 | 79 | 0.030 |
Why?
|
| Child Behavior Disorders | 1 | 2001 | 805 | 0.030 |
Why?
|
| Aortic Valve | 1 | 1986 | 1996 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 1997 | 392 | 0.030 |
Why?
|
| Rett Syndrome | 1 | 1997 | 164 | 0.030 |
Why?
|
| Rwanda | 1 | 2018 | 659 | 0.030 |
Why?
|
| Receptors, Erythropoietin | 1 | 2016 | 144 | 0.030 |
Why?
|
| Orofaciodigital Syndromes | 1 | 1995 | 21 | 0.030 |
Why?
|
| Cerebral Palsy | 1 | 2020 | 471 | 0.030 |
Why?
|
| Child Abuse | 1 | 2004 | 1067 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2005 | 3215 | 0.030 |
Why?
|
| Taurine | 1 | 1996 | 93 | 0.030 |
Why?
|
| Deoxyglucose | 2 | 1994 | 333 | 0.030 |
Why?
|
| Health Surveys | 2 | 2013 | 4063 | 0.030 |
Why?
|
| Oxygen Consumption | 2 | 1999 | 1843 | 0.030 |
Why?
|
| Calpain | 1 | 2016 | 145 | 0.030 |
Why?
|
| Risk Assessment | 5 | 2015 | 24123 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 1998 | 409 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2001 | 1677 | 0.030 |
Why?
|
| Receptors, Kainic Acid | 1 | 1995 | 90 | 0.030 |
Why?
|
| Ventilators, Mechanical | 1 | 1997 | 287 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2022 | 5961 | 0.030 |
Why?
|
| Linear Models | 1 | 2005 | 5877 | 0.030 |
Why?
|
| Diseases in Twins | 1 | 1997 | 447 | 0.030 |
Why?
|
| Hospitals, Public | 1 | 1996 | 201 | 0.030 |
Why?
|
| Hyperplasia | 1 | 1998 | 1155 | 0.030 |
Why?
|
| Respiratory System | 1 | 1998 | 557 | 0.030 |
Why?
|
| Depersonalization | 1 | 2014 | 39 | 0.030 |
Why?
|
| Nitroglycerin | 1 | 1996 | 329 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2020 | 1134 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1998 | 1792 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2017 | 987 | 0.030 |
Why?
|
| Infant, Small for Gestational Age | 1 | 1997 | 460 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 550 | 0.030 |
Why?
|
| Treatment Failure | 2 | 1999 | 2648 | 0.030 |
Why?
|
| Referral and Consultation | 2 | 2013 | 3598 | 0.030 |
Why?
|
| Mathematical Concepts | 1 | 2014 | 73 | 0.030 |
Why?
|
| Tracheal Stenosis | 1 | 1996 | 226 | 0.030 |
Why?
|
| Glucose | 2 | 1998 | 4351 | 0.030 |
Why?
|
| Cephalometry | 1 | 2015 | 382 | 0.030 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2016 | 238 | 0.030 |
Why?
|
| Calorimetry, Indirect | 1 | 2014 | 174 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 1995 | 323 | 0.030 |
Why?
|
| Home Care Services | 1 | 2010 | 654 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 1999 | 741 | 0.030 |
Why?
|
| Fever | 1 | 2021 | 1617 | 0.030 |
Why?
|
| Disease Transmission, Infectious | 2 | 1999 | 558 | 0.030 |
Why?
|
| Esophageal Atresia | 1 | 1996 | 217 | 0.030 |
Why?
|
| Symporters | 1 | 2016 | 361 | 0.030 |
Why?
|
| Achievement | 1 | 2014 | 289 | 0.030 |
Why?
|
| Benzamides | 1 | 1998 | 1369 | 0.030 |
Why?
|
| Retina | 1 | 2023 | 2635 | 0.030 |
Why?
|
| Rhombencephalon | 1 | 2012 | 81 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2020 | 981 | 0.030 |
Why?
|
| Histological Techniques | 1 | 1992 | 194 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 718 | 0.030 |
Why?
|
| Stereotaxic Techniques | 1 | 1995 | 549 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2018 | 1139 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1996 | 1544 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2020 | 1032 | 0.020 |
Why?
|
| Organizational Policy | 1 | 2014 | 429 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1995 | 563 | 0.020 |
Why?
|
| Stomach | 1 | 1996 | 694 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2020 | 2029 | 0.020 |
Why?
|
| Potassium | 1 | 1996 | 1313 | 0.020 |
Why?
|
| Kainic Acid | 1 | 1991 | 199 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2020 | 1504 | 0.020 |
Why?
|
| Synapses | 1 | 2001 | 1757 | 0.020 |
Why?
|
| Blood Pressure Monitors | 1 | 1991 | 33 | 0.020 |
Why?
|
| Decompression, Surgical | 2 | 2008 | 604 | 0.020 |
Why?
|
| Transducers, Pressure | 1 | 1991 | 51 | 0.020 |
Why?
|
| Brain Mapping | 2 | 2005 | 6568 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2001 | 10182 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 1996 | 1809 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2014 | 1578 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 12531 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 1992 | 576 | 0.020 |
Why?
|
| Family Health | 1 | 1994 | 1257 | 0.020 |
Why?
|
| Health Personnel | 1 | 2023 | 3310 | 0.020 |
Why?
|
| Terminal Care | 1 | 2011 | 1758 | 0.020 |
Why?
|
| Rest | 1 | 2014 | 914 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 1995 | 978 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 1996 | 816 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2006 | 5397 | 0.020 |
Why?
|
| Partial Pressure | 2 | 1999 | 245 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2013 | 1722 | 0.020 |
Why?
|
| Cerebral Ventriculography | 1 | 2008 | 44 | 0.020 |
Why?
|
| Goals | 1 | 2013 | 708 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1998 | 3726 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 2571 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 9716 | 0.020 |
Why?
|
| HIV Infections | 1 | 1994 | 17165 | 0.020 |
Why?
|
| Ophthalmoscopy | 1 | 2008 | 171 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 14495 | 0.020 |
Why?
|
| North America | 1 | 2010 | 1284 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 10181 | 0.020 |
Why?
|
| Food Additives | 1 | 1986 | 23 | 0.020 |
Why?
|
| Comorbidity | 2 | 2015 | 10551 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2008 | 527 | 0.020 |
Why?
|
| Diabetes Insipidus | 1 | 2006 | 144 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2017 | 2056 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2006 | 5870 | 0.020 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1986 | 173 | 0.020 |
Why?
|
| Puberty, Precocious | 1 | 2006 | 163 | 0.020 |
Why?
|
| Differential Threshold | 1 | 2005 | 80 | 0.020 |
Why?
|
| Wounds and Injuries | 2 | 2010 | 2477 | 0.010 |
Why?
|
| Orbit | 1 | 2008 | 446 | 0.010 |
Why?
|
| Potassium Deficiency | 1 | 2004 | 10 | 0.010 |
Why?
|
| APACHE | 1 | 2004 | 267 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3465 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2017 | 6218 | 0.010 |
Why?
|
| Periodicity | 1 | 2005 | 348 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 1343 | 0.010 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2004 | 87 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2014 | 2963 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 2010 | 965 | 0.010 |
Why?
|
| Nutrition Therapy | 1 | 2005 | 102 | 0.010 |
Why?
|
| Hypophosphatemia | 1 | 2004 | 93 | 0.010 |
Why?
|
| Caspase 1 | 1 | 2004 | 226 | 0.010 |
Why?
|
| Nutrition Disorders | 1 | 2004 | 205 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 1997 | 2859 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 192 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 25942 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1997 | 3455 | 0.010 |
Why?
|
| Disease Management | 1 | 2013 | 2514 | 0.010 |
Why?
|
| Interleukin-18 | 1 | 2004 | 251 | 0.010 |
Why?
|
| Extracellular Fluid | 1 | 2004 | 165 | 0.010 |
Why?
|
| Emotions | 1 | 2014 | 2734 | 0.010 |
Why?
|
| National Health Programs | 1 | 2006 | 441 | 0.010 |
Why?
|
| Proteins | 1 | 1997 | 6029 | 0.010 |
Why?
|
| Cardiovascular Agents | 1 | 2009 | 867 | 0.010 |
Why?
|
| Vaccination | 1 | 1994 | 3361 | 0.010 |
Why?
|
| Organ Culture Techniques | 2 | 1995 | 796 | 0.010 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2005 | 269 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2004 | 780 | 0.010 |
Why?
|
| Renal Replacement Therapy | 1 | 2004 | 281 | 0.010 |
Why?
|
| Cebidae | 1 | 1981 | 21 | 0.010 |
Why?
|
| Muscle Hypertonia | 1 | 1981 | 12 | 0.010 |
Why?
|
| Survivors | 1 | 2012 | 2375 | 0.010 |
Why?
|
| Hypothalamus | 1 | 2006 | 998 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7408 | 0.010 |
Why?
|
| Coronavirus | 1 | 2003 | 149 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2004 | 1033 | 0.010 |
Why?
|
| Functional Laterality | 1 | 1967 | 2253 | 0.010 |
Why?
|
| Saimiri | 1 | 1981 | 334 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8624 | 0.010 |
Why?
|
| Craniotomy | 1 | 2005 | 741 | 0.010 |
Why?
|
| Phosphates | 1 | 2004 | 772 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 2005 | 814 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 18137 | 0.010 |
Why?
|
| Seasons | 1 | 2005 | 1522 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 2004 | 783 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8950 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2004 | 1135 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2004 | 975 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2014 | 3620 | 0.010 |
Why?
|
| Violence | 1 | 2004 | 927 | 0.010 |
Why?
|
| Walking | 1 | 2005 | 1189 | 0.010 |
Why?
|
| Alkalosis | 1 | 1997 | 54 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 1999 | 224 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2004 | 1479 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 3276 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2004 | 1765 | 0.010 |
Why?
|
| Pancreatitis | 1 | 2004 | 1100 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2004 | 1341 | 0.010 |
Why?
|
| Muscles | 1 | 1981 | 1581 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2004 | 1810 | 0.010 |
Why?
|
| Leucine | 1 | 1997 | 547 | 0.010 |
Why?
|
| Phenylalanine | 1 | 1997 | 365 | 0.010 |
Why?
|
| Quisqualic Acid | 1 | 1995 | 35 | 0.010 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1995 | 70 | 0.010 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 1995 | 39 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 4122 | 0.010 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 1999 | 326 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 7806 | 0.010 |
Why?
|
| Potassium Cyanide | 1 | 1994 | 17 | 0.010 |
Why?
|
| Frozen Sections | 1 | 1995 | 153 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1999 | 1832 | 0.010 |
Why?
|
| Glycine | 1 | 1997 | 662 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1986 | 3811 | 0.010 |
Why?
|
| Gastric Emptying | 1 | 1996 | 243 | 0.010 |
Why?
|
| Motor Cortex | 1 | 1981 | 995 | 0.010 |
Why?
|
| Biopsy | 2 | 1996 | 6771 | 0.010 |
Why?
|
| Echocardiography | 1 | 1986 | 4981 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 1997 | 506 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3707 | 0.010 |
Why?
|
| Vital Capacity | 1 | 1996 | 965 | 0.010 |
Why?
|
| Heart Failure | 1 | 1997 | 11847 | 0.010 |
Why?
|
| Pyramidal Tracts | 1 | 1994 | 250 | 0.010 |
Why?
|
| Propidium | 1 | 1991 | 42 | 0.010 |
Why?
|
| Age of Onset | 1 | 1999 | 3301 | 0.010 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1999 | 1348 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 1994 | 495 | 0.010 |
Why?
|
| Foreign Bodies | 1 | 1996 | 397 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1995 | 1098 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2005 | 2543 | 0.010 |
Why?
|
| Anthropometry | 1 | 1996 | 1348 | 0.010 |
Why?
|
| Communication | 1 | 2005 | 3849 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 8552 | 0.010 |
Why?
|
| Catheterization | 1 | 1996 | 1432 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1991 | 412 | 0.010 |
Why?
|
| Deglutition Disorders | 1 | 1996 | 626 | 0.010 |
Why?
|
| Glycolysis | 1 | 1994 | 828 | 0.010 |
Why?
|
| Body Height | 1 | 1996 | 1570 | 0.010 |
Why?
|
| Cleft Palate | 1 | 1995 | 587 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 1995 | 857 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1986 | 4673 | 0.010 |
Why?
|
| Fluorescence | 1 | 1991 | 751 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 1997 | 2417 | 0.000 |
Why?
|
| Delivery of Health Care | 1 | 2006 | 5325 | 0.000 |
Why?
|
| Middle Aged | 4 | 2014 | 220352 | 0.000 |
Why?
|
| Cause of Death | 1 | 1998 | 3725 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1991 | 1089 | 0.000 |
Why?
|
| Sodium Glutamate | 1 | 1986 | 23 | 0.000 |
Why?
|
| Naphthalenesulfonates | 1 | 1986 | 15 | 0.000 |
Why?
|
| Sensation | 1 | 1967 | 331 | 0.000 |
Why?
|
| Organic Chemicals | 1 | 1986 | 211 | 0.000 |
Why?
|
| Body Weight | 1 | 1996 | 4611 | 0.000 |
Why?
|
| Mouth | 1 | 1986 | 380 | 0.000 |
Why?
|
| Hypersensitivity, Immediate | 1 | 1986 | 345 | 0.000 |
Why?
|
| Aged | 3 | 2004 | 169152 | 0.000 |
Why?
|
| Extremities | 1 | 1967 | 867 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1998 | 15289 | 0.000 |
Why?
|
| Cerebral Decortication | 1 | 1981 | 11 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 13630 | 0.000 |
Why?
|
| Movement | 1 | 1967 | 1474 | 0.000 |
Why?
|
| Face | 1 | 1986 | 1017 | 0.000 |
Why?
|
| Meningioma | 1 | 1967 | 1221 | 0.000 |
Why?
|
| Food Hypersensitivity | 1 | 1986 | 697 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1995 | 11481 | 0.000 |
Why?
|
| Electromyography | 1 | 1981 | 1388 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1995 | 58995 | 0.000 |
Why?
|